# A PHASE 1B STUDY OF ZN-C5 IN CHINESE SUBJECTS

> **NCT04852419** · PHASE1 · COMPLETED · sponsor: **Zentera Therapeutics HK Limited** · enrollment: 12 (actual)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DRUG:** ZN-c5

## Key facts

- **NCT ID:** NCT04852419
- **Lead sponsor:** Zentera Therapeutics HK Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-31
- **Primary completion:** 2022-06-23
- **Final completion:** 2022-06-23
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04852419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04852419, "A PHASE 1B STUDY OF ZN-C5 IN CHINESE SUBJECTS". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04852419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*